Thalidomide News and Research

RSS
Thalidomide is a drug that is used to treat multiple myeloma in patients who have just been diagnosed, and a painful skin disease related to leprosy. It is also being studied in the treatment of other types of cancer. Thalidomide belongs to the family of drugs called angiogenesis inhibitors. Also called Thalomid.
Study identifies critical genes and biological pathways related to COVID-19 myocarditis

Study identifies critical genes and biological pathways related to COVID-19 myocarditis

Study reveals the benefits of using thalidomide in patients with severe arteriovenous malformations

Study reveals the benefits of using thalidomide in patients with severe arteriovenous malformations

Addition of left-handed chiral gold nanoparticles can enhance vaccine efficacy by more than 25%

Addition of left-handed chiral gold nanoparticles can enhance vaccine efficacy by more than 25%

Improving our understanding of a severe pregnancy sickness (Hyperemesis Gravidarum)

Improving our understanding of a severe pregnancy sickness (Hyperemesis Gravidarum)

New analysis method to identify interacting proteins in a protein degrader-dependent manner

New analysis method to identify interacting proteins in a protein degrader-dependent manner

Clinical trial shows preliminary efficacy of all-oral regimen for patients with lenalidomide-refractory multiple myeloma

Clinical trial shows preliminary efficacy of all-oral regimen for patients with lenalidomide-refractory multiple myeloma

Benjamin L. Ebert receives Sjöberg Prize for breakthrough research on blood cancer

Benjamin L. Ebert receives Sjöberg Prize for breakthrough research on blood cancer

Immunomodulatory drugs improve the success rate of cancer therapies

Immunomodulatory drugs improve the success rate of cancer therapies

Immune-inflammatory mediators indicate that rejection and tissue injury can be avoided with drugs

Immune-inflammatory mediators indicate that rejection and tissue injury can be avoided with drugs

Sky-high drug prices driven by pharma profits, House Dems charge

Sky-high drug prices driven by pharma profits, House Dems charge

Researchers investigate molecular mechanism responsible for hypnotic effects of thalidomide

Researchers investigate molecular mechanism responsible for hypnotic effects of thalidomide

Researchers develop scalable strategy to find novel molecular glue degraders

Researchers develop scalable strategy to find novel molecular glue degraders

Scientists design chiral ligands to generate useful compounds

Scientists design chiral ligands to generate useful compounds

TPU researchers develop supersensitive sensors to detect enantiomers in drugs

TPU researchers develop supersensitive sensors to detect enantiomers in drugs

New method uses human embryonic stem cells to generate 3D assembly of cells

New method uses human embryonic stem cells to generate 3D assembly of cells

One-size-fits-all approach does not work for treating pregnant women with hypertension

One-size-fits-all approach does not work for treating pregnant women with hypertension

New method determines the atomic structure of natural products more rapidly, accurately

New method determines the atomic structure of natural products more rapidly, accurately

Researchers develop novel mouse model to study immunomodulatory therapies

Researchers develop novel mouse model to study immunomodulatory therapies

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer